EE355 The Budgetary Consequences of Increasing Utilization of Dronedarone Relative to Other Antiarrythmic Drugs to a Hypothetical U.S. Payer
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.603
https://www.valueinhealthjournal.com/article/S1098-3015(22)00804-X/fulltext
Title :
EE355 The Budgetary Consequences of Increasing Utilization of Dronedarone Relative to Other Antiarrythmic Drugs to a Hypothetical U.S. Payer
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00804-X&doi=10.1016/j.jval.2022.04.603
First page :
Section Title :
Open access? :
No
Section Order :
10538